- Home
- FG vs CORT Comparison
FG vs CORT Comparison
Compare FG & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FG | CORT |
|---|---|---|
| Founded | 1959 | 1998 |
| Country | United States | United States |
| Employees | 1173 | N/A |
| Industry | Life Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.7B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | FG | CORT |
|---|---|---|
| Price | $29.46 | $51.52 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 5 |
| Target Price | $31.00 | ★ $96.50 |
| AVG Volume (30 Days) | 490.5K | ★ 981.4K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $761,407,000.00 |
| Revenue This Year | $7.94 | $26.08 |
| Revenue Next Year | $5.51 | $26.98 |
| P/E Ratio | $8.41 | ★ N/A |
| Revenue Growth | N/A | ★ 12.79 |
| 52 Week Low | $20.57 | $28.66 |
| 52 Week High | $36.70 | $91.00 |
Technical Indicators
Market Signals| Indicator | FG | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 71.59 | 76.45 |
| Support Level | $28.75 | $32.95 |
| Resistance Level | $29.63 | $75.20 |
| Average True Range (ATR) | 0.75 | 1.93 |
| MACD | 0.14 | 0.44 |
| Stochastic Oscillator | 98.32 | 89.41 |
Price Performance
Historical ComparisonAbout FG F&G Annuities & Life Inc.
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.